In April 2023, as part of a European Union research initiative, a European academic conducted an in-depth interview with CHIL Founder Hilda Cil for CORONOMICS, exploring the global pandemic and its ongoing implications for healthcare, diagnostics, and public health strategy. The conversation highlighted CHIL’s experiences during COVID-19, its innovative responses, and lessons learned for building resilient healthcare systems in a post-pandemic world.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.